ONCT

Oncternal Therapeutics, Inc. Common Stock
ONCT

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ONCT was delisted on the 2nd of December, 2024.

Back to rankings

21 hedge funds and large institutions have $4.98M invested in Oncternal Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
21
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$651K
2
+$83K
3
+$54K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$11.3K
5
Morgan Stanley
Morgan Stanley
New York
+$11.1K

Top Sellers

1
-$119K
2
-$66K
3
-$49.6K
4
DY
Dowling & Yahnke
California
-$27K
5
TRCT
Tower Research Capital (TRC)
New York
-$16.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.89M
2
$1.13M
3
$495K
4
$306K
5
$277K
6
$269K
7
$139K
8
$92K
9
$83K
10
$67K
11
$54K
12
$52K
13
$47K
14
$40K
15
$19K
16
$17K
17
$8K
18
$2K
19
$1K
20
$1K
21
$1K
22
$16
23
–
24
–